ORTINGLOBE · Healthcare · Drug Manufacturers - Specialty & Generic
| Share price | ₹15.14 |
| Market cap | ₹12 Cr |
| P/B ratio | 11.4 |
| ROE | -9.1% |
| ROCE | -32.1% |
| Book value | ₹1.33 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹0 Cr | ₹-1 Cr | -717.6% |
| 2025 | ₹0 Cr | ₹-1 Cr | -249.6% |
| 2024 | ₹2 Cr | ₹-8 Cr | -211.7% |
| 2023 | ₹6 Cr | ₹-0 Cr | 4.5% |
| 2022 | — | — | — |
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations